| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |